An edition of Prescription for the people
(2017)
Prescription for the people
an activist's guide to making medicine affordable for all
by Fran Quigley
- 0 Ratings
- 0 Want to read
- 0 Currently reading
- 0 Have read
Share
×Close
"In Prescription for the People, Fran Quigley diagnoses our inability to get medicines to the people who need them and then prescribes the cure. He delivers a clear and convincing argument for a complete shift in the global and U. S. approach to developing and providing argument for a complete shift in the global and U.S. approach to developing and providing essential medicines -- and a primer on how to make that change happen." --
Check nearby libraries
Buy this book
Subjects
Pharmaceutical industry, Prices, Drug accessibility, Pharmaceutical policy, Drugs, Health care reform, Prescription pricing, Drugs, prices, Medical policy, Pharmaceutical Fees, Ethics, Drug Industry, Economics, Health Care Reform, Health Policy, Patient Rights, Médicaments, Prix, Accessibilité, Politique gouvernementale, Industrie pharmaceutique, Services de santé, Réforme, Politique sanitaire, BUSINESS & ECONOMICS, Industries, GeneralPlaces
United StatesShowing 1 featured edition. View all 1 editions?
| Edition | Availability |
|---|---|
1
Prescription for the people: an activist's guide to making medicine affordable for all
2017, ILR Press, an imprint of Cornell University Press
in English
1501713752 9781501713750
|
aaaa
Libraries near you:
WorldCat
|
Book Details
Table of Contents
People everywhere are struggling to get the medicines they need
The United States has a drug problem
Millions of people are dying needlessly
Cancer patients face particularly deadly barriers to medicines
The current medicine system neglects many major diseases
Corporate research and development investments are exaggerated
The current system wastes billions on drug marketing
The current system compromises physician integrity and leads to unethical corporate behavior
Medicines are priced at whatever the market will bear
Pharmaceutical corporations reap history-making profits
The for-profit medicine arguments are patently false
Medicine patents are extended too far and too wide
Patent protectionism stunts the development of new medicines
Governments, not private corporations, drive medicine innovation
Taxpayers and patients pay twice for patented medicines
Medicines are a public good
Medicine patents are artificial, recent, and government-created
The United States and big pharma play the bully in extending patents
Pharma-pushed trade agreements steal the power of democratically elected governments
Current law provides opportunities for affordable generic medicines
There is a better way to develop medicines
Human rights law demands access to essential medicines.
Edition Notes
Includes bibliographical references and index.
Classifications
The Physical Object
ID Numbers
Community Reviews (0)
Feedback?
History
- Created May 24, 2019
- 6 revisions
Wikipedia citation
×CloseCopy and paste this code into your Wikipedia page. Need help?
| March 8, 2023 | Edited by MARC Bot | import existing book |
| December 15, 2022 | Edited by MARC Bot | import existing book |
| December 10, 2022 | Edited by ImportBot | import existing book |
| October 11, 2020 | Edited by ImportBot | import existing book |
| May 24, 2019 | Created by MARC Bot | Imported from marc_openlibraries_sanfranciscopubliclibrary MARC record. |